Edgewell Personal Care Company · NYSE:EPC
Edgewell Personal Care — Q1 2026 Earnings Presentation
14 slides from Edgewell Personal Care's earnings presentation, Feb 9, 2026
Slide 1: Q1 Fiscal Year 2026 Supplemental Slides
Q1 Fiscal Year 2026 Supplemental Slides Supplemental Information Related to Company’s Divestiture of its Feminine Care Business PAGE 1
Slide 2: Forward-looking statements
Forward-looking statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on these statements. Forward-looking statements generally can
Slide 3: Non-GAAP financial measures
Non-GAAP financial measures While the Company reports financial results in accordance with generally accepted accounting principles ("GAAP") in the U.S., this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as "adjusted" or "organic" and exclude items which are co
Slide 4: Fiscal Year 2025 Recast Continuing Operations Financial Information (Unaudited)
Fiscal Year 2025 Recast Continuing Operations Financial Information (Unaudited) PAGE 4
Slide 5: FY25 Recast Continuing Operations Financial Information
Fiscal Year 2025 (“FY25”) Recast Continuing Operations Financial Information (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 Recast Recast Recast Recast Recast Disc Ops Disc Ops Disc Ops Disc Ops Disc Ops Income Statement Reported (1) Cont. Ops Reported (1) Cont. Ops Reported (1) Cont. Ops Reported (1)
Slide 6: Fiscal Year 2025 Recast Continuing Operations – Reconciliation Tables
Fiscal Year 2025 Recast Continuing Operations – Reconciliation Tables (Unaudited) PAGE 6
Slide 7: FY25 Continuing Operations Reconciliation Table – Gross Profit
FY25 Continuing Operations Reconciliation Table – Gross Profit (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ 172.5 $ 236.9 $ 250.1 $ 188.3 $ 847.8 Restructuring and related costs — — 1.2 2.3 3.5 Acquisition and integration costs — — — — — Sun Care reformulation co
Slide 8: FY25 Continuing Operations Reconciliation Table – SG&A
FY25 Continuing Operations Reconciliation Table – SG&A (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ 99.6 $ 102.8 $ 100.7 $ 105.5 $ 408.6 Restructuring and related costs — — (0.6) (1.1) (1.7) Acquisition and integration costs (0.5) — — — (0.5) Sun Care reformulati
Slide 9: FY25 Continuing Operations Reconciliation Table – Operating Income
FY25 Continuing Operations Reconciliation Table – Operating Income (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ 9.3 $ 49.0 $ 45.0 $ 6.9 $ 110.2 Restructuring and related costs 4.1 11.9 16.7 18.1 50.8 Acquisition and integration costs 0.5 — — — 0.5 Sun Care reform
Slide 10: FY25 Continuing Operations Reconciliation Table – EBIT
FY25 Continuing Operations Reconciliation Table – EBIT(1) (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ (12.7) $ 31.4 $ 28.5 $ (10.0) $ 37.2 Restructuring and related costs 4.1 11.9 16.7 18.1 50.8 Acquisition and integration costs 0.5 — — — 0.5 Sun Care reformulat
Slide 11: FY25 Continuing Operations Reconciliation Table – Income Tax Provision (Benefit)
FY25 Continuing Operations Reconciliation Table – Income Tax Provision (Benefit) (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ (2.6) $ 10.6 $ 7.0 $ (22.2) $ (7.2) Restructuring and related costs 1.0 3.0 4.1 4.4 12.5 Acquisition and integration costs 0.1 — — — 0.1
Slide 12: FY25 Continuing Operations Reconciliation Table – Net Earnings (Loss)
FY25 Continuing Operations Reconciliation Table – Net Earnings (Loss) (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ (10.1) $ 20.8 $ 21.5 $ 12.2 $ 44.4 Restructuring and related costs 3.1 8.8 12.6 13.8 38.3 Acquisition and integration costs 0.4 — — — 0.4 Sun Care r
Slide 13: FY25 Continuing Operations Reconciliation Table – Diluted EPS
FY25 Continuing Operations Reconciliation Table – Diluted EPS (Unaudited, in millions, except per share data) Q1 Q2 Q3 Q4 FY25 GAAP — Recast Continuing Operations $ (0.21) $ 0.43 $ 0.46 $ 0.26 $ 0.93 Restructuring and related costs 0.07 0.18 0.26 0.30 0.80 Acquisition and integration costs 0.01 — —
Slide 14: FY25 Continuing Operations Reconciliation Table – EBITDA
FY25 Continuing Operations Reconciliation Table – EBITDA (Unaudited, $ in millions) Q1 Q2 Q3 Q4 FY25 Net earnings (loss) from continuing operations $ (10.1) $ 20.8 $ 21.5 $ 12.2 $ 44.4 Income tax provision (2.6) 10.6 7.0 (22.2) (7.2) Interest expense, net 18.3 19.6 19.0 14.2 71.1 Depreciation and am
Edgewell Personal Care Company — Q1 2026 Earnings Presentation on 6ix